Generic drug antitrust case can 'bend the curve' on costs, NAAG president says
The new president of the National Association of Attorneys General, Connecticut Attorney General William Tong, said Wednesday that the antitrust suit brought by a coalition of states against three dozen generic...To view the full article, register now.
Already a subscriber? Click here to view full article